Humana Inc. $HUM Position Lifted by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp grew its stake in shares of Humana Inc. (NYSE:HUMFree Report) by 0.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,664 shares of the insurance provider’s stock after acquiring an additional 521 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.05% of Humana worth $15,076,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of HUM. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares during the last quarter. Zions Bancorporation National Association UT acquired a new stake in Humana during the first quarter valued at approximately $37,000. CVA Family Office LLC lifted its holdings in Humana by 63.4% during the 2nd quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after buying an additional 85 shares during the last quarter. Ransom Advisory Ltd bought a new position in Humana during the 1st quarter worth approximately $66,000. Finally, Transamerica Financial Advisors LLC grew its position in shares of Humana by 1,027.6% in the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 298 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of several research reports. Truist Financial dropped their price target on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Wolfe Research boosted their target price on shares of Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a research note on Monday, October 6th. Bank of America increased their target price on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Wells Fargo & Company lifted their price target on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Eight investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus target price of $298.39.

Read Our Latest Stock Analysis on Humana

Humana Trading Up 0.1%

Shares of NYSE:HUM opened at $236.94 on Friday. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The company’s 50-day moving average price is $271.04 and its 200 day moving average price is $258.04. The company has a market cap of $28.50 billion, a PE ratio of 18.18, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35.

Humana (NYSE:HUMGet Free Report) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. The firm had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.16 EPS. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.5%. Humana’s payout ratio is presently 33.18%.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.